{
      "Rank": 1,
      "Acronym": [],
      "AgreementOtherDetails": [],
      "AgreementPISponsorEmployee": [],
      "AgreementRestrictionType": [],
      "AgreementRestrictiveAgreement": [],
      "ArmGroupDescription": [
            "MSC infusion for steroid-refractory grade II-IV acute GVHD. In this arm, 4 x 10E6 MSC/Kg BW of the recipient will be injected during the first hour after thawing.",
            "MSC infusion for poor graft function. In this arm, 2 x 10E6 MSC/Kg BW of the recipient will be injected during the first hour after thawing.",
            "MSC + DLI for poor donor T-cell chimerism after allogeneic HCT. In this arm, 2 x 10E6 MSC/Kg BW of the recipient will be injected during the first hour after thawing."
      ],
      "ArmGroupInterventionName": [
            "Biological: Mesenchymal stem cells",
            "Biological: Mesenchymal stem cells",
            "Biological: Mesenchymal stem cells"
      ],
      "ArmGroupLabel": [
            "1",
            "2",
            "3"
      ],
      "ArmGroupType": [
            "Experimental",
            "Experimental",
            "Experimental"
      ],
      "AvailIPDComment": [],
      "AvailIPDId": [],
      "AvailIPDType": [],
      "AvailIPDURL": [],
      "BaselineCategoryTitle": [],
      "BaselineClassDenomCountGroupId": [],
      "NCTId": [
            "NCT00603330"
      ],
      "BaselineClassDenomCountValue": [],
      "BaselineClassDenomUnits": [],
      "BaselineClassTitle": [],
      "BaselineDenomCountGroupId": [],
      "BaselineDenomCountValue": [],
      "BaselineDenomUnits": [],
      "BaselineGroupDescription": [],
      "BaselineGroupId": [],
      "BaselineGroupTitle": [],
      "BaselineMeasureCalculatePct": [],
      "BaselineMeasureDenomCountGroupId": [],
      "BaselineMeasureDenomCountValue": [],
      "BaselineMeasureDenomUnits": [],
      "BaselineMeasureDenomUnitsSelected": [],
      "BaselineMeasureDescription": [],
      "BaselineMeasureDispersionType": [],
      "BaselineMeasureParamType": [],
      "BaselineMeasurePopulationDescription": [],
      "BaselineMeasureTitle": [],
      "BaselineMeasureUnitOfMeasure": [],
      "BaselineMeasurementComment": [],
      "BaselineMeasurementGroupId": [],
      "BaselineMeasurementLowerLimit": [],
      "BaselineMeasurementSpread": [],
      "BaselineMeasurementUpperLimit": [],
      "BaselineMeasurementValue": [],
      "BaselinePopulationDescription": [],
      "BaselineTypeUnitsAnalyzed": [],
      "BioSpecDescription": [],
      "BioSpecRetention": [],
      "BriefSummary": [
            "The present project aims at investigating the role of MSC for the treatment of patients with\n\nPart 1: Steroid-refractory grade II-IV acute GVHD.\n\nPart 2: Poor graft function (PGF)\n\nPart 3: Low or falling donor T-cell chimerism after allogeneic HCT.\n\nThis is a multicenter phase II study examining the feasibility and efficacy of this approach."
      ],
      "BriefTitle": [
            "Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function"
      ],
      "CentralContactEMail": [
            "yves.beguin@chu.ulg.ac.be",
            "F.Baron@ulg.ac.be"
      ],
      "CentralContactName": [
            "Yves Beguin, MD, PhD",
            "Frederic Baron, MD, PhD"
      ],
      "CentralContactPhone": [
            "32-4-366 72 01",
            "32-4-366 72 01"
      ],
      "CentralContactPhoneExt": [],
      "CentralContactRole": [
            "Contact",
            "Contact"
      ],
      "CollaboratorClass": [
            "OTHER",
            "OTHER",
            "OTHER",
            "OTHER",
            "OTHER",
            "OTHER",
            "OTHER",
            "OTHER",
            "OTHER",
            "UNKNOWN",
            "OTHER"
      ],
      "CollaboratorName": [
            "KU Leuven",
            "Maastricht University Medical Center",
            "Ziekenhuis Netwerk Antwerpen (ZNA)",
            "University Hospital, Antwerp",
            "University Hospital, Ghent",
            "AZ-VUB",
            "AZ Sint-Jan AV",
            "Cliniques universitaires Saint-Luc- Universit\u00e9 Catholique de Louvain",
            "University Hospital of Mont-Godinne",
            "Jolimont Hospital Haine Saint Paul",
            "Queen Fabiola Children's University Hospital"
      ],
      "CompletionDate": [
            "August 2024"
      ],
      "CompletionDateType": [
            "Anticipated"
      ],
      "Condition": [
            "Graft-versus-host Disease",
            "Poor Graft Function",
            "Low Donor T-cell Chimerism"
      ],
      "ConditionAncestorId": [
            "D000007154"
      ],
      "ConditionAncestorTerm": [
            "Immune System Diseases"
      ],
      "ConditionBrowseBranchAbbrev": [
            "BC20",
            "All",
            "Rare"
      ],
      "ConditionBrowseBranchName": [
            "Immune System Diseases",
            "All Conditions",
            "Rare Diseases"
      ],
      "ConditionBrowseLeafAsFound": [
            "Graft Versus Host Disease",
            "Graft Versus Host Disease"
      ],
      "ConditionBrowseLeafId": [
            "M8341",
            "M9352",
            "T2832",
            "T170"
      ],
      "ConditionBrowseLeafName": [
            "Graft vs Host Disease",
            "Immune System Diseases",
            "Homologous Wasting Disease",
            "Acute Graft Versus Host Disease"
      ],
      "ConditionBrowseLeafRelevance": [
            "high",
            "low",
            "high",
            "low"
      ],
      "ConditionMeshId": [
            "D000006086"
      ],
      "ConditionMeshTerm": [
            "Graft vs Host Disease"
      ],
      "DelayedPosting": [],
      "DesignAllocation": [
            "Non-Randomized"
      ],
      "DesignInterventionModel": [
            "Single Group Assignment"
      ],
      "DesignInterventionModelDescription": [],
      "DesignMasking": [
            "None (Open Label)"
      ],
      "DesignMaskingDescription": [],
      "DesignObservationalModel": [],
      "DesignPrimaryPurpose": [
            "Treatment"
      ],
      "DesignTimePerspective": [],
      "DesignWhoMasked": [],
      "DetailedDescription": [
            "Part 1: complete recruitment Part 2: complete recruitment Part 3: recruiting"
      ],
      "DispFirstPostDate": [],
      "DispFirstPostDateType": [],
      "DispFirstSubmitDate": [],
      "DispFirstSubmitQCDate": [],
      "EligibilityCriteria": [
            "Inclusion Criteria:\n\nPatient eligibility criteria\n\nMale or female of any age.\nPrevious allogeneic transplantation (related or unrelated donor, any degree of HLA matching) or autologous transplantation (for part 2 only) of HSC at any time before.\nAny source of HSC (marrow, PBSC, cord blood) and any conditioning regimen.\nInformed consent given by donor or his/her guardian if of minor age.\nAdditional criteria for each part of the protocol:\n\nPart 1: MSC for steroid-refractory grade II-IV acute GVHD\n\nAllogeneic transplantation.\nGrade II-IV acute GVHD (see appendix A for acute GVHD grading) de novo or following DLI.\n\nAcute GVHD refractory to mPDN 2 mg/kg/day or equivalent, defined as\n\nprogression of GVHD on day 3 after initiation of steroids\nno improvement of GVHD on day 7 after initiation of steroids\nabsence of complete resolution of acute GVHD on day 14 after initiation of steroids\nrelapse of acute GVHD during or after steroid taper.\nOngoing therapy with Ciclosporine or Tacrolimus at therapeutic doses.\nPatient may have received previously any other form of treatment for acute GVHD, but no new treatment started within 1 month of study entry.\n\nPart 2: MSC for poor graft function (PGF)\n\nAllogeneic or autologous transplantation.\n\nCytopenia in 2 or 3 lineages:\n\nHb < 8.0 g/dL and reticulocytes < 1%, with or without transfusion\nPlt < 20,000/\u00b5L without transfusion\nNeutrophils < 500/\u00b5L, without G-CSF administration\n\nOR severe cytopenia in 1 lineage:\n\nRBC transfusion dependent (if autologous transplantation; despite EPO administration if allogeneic transplantation)\nPlt transfusion dependent\nNeutrophils < 500/\u00b5L despite G-CSF administration\nCytopenia duration \u2265 2 weeks beyond day 28 after autologous HCT, or day 42 (day 60 for cord blood transplantation) after allogeneic HCT.\nCytopenia is not related to CMV or other infection, myelosuppressive/toxic drugs, renal failure, peripheral cell destruction or other identifiable cause.\nIn case of HLA-identical related donor and full donor chimerism, patient can only be included if a boost of donor CD34+ cells has been unsuccessful or is not feasible.\n\nPart 3: MSC + DLI for poor donor T-cell chimerism\n\nNonmyeloablative allogeneic transplantation.\n\nDonor T-cell chimerism < 50% for at least 2 consecutive weeks beyond day 21 after HCT OR\n\n20% decrease in donor T-cell chimerism with the second value < 50%.\n\nMSC donor inclusion criteria\n\nRelated to the recipient (sibling, parent or child) or unrelated.\nMale or female.\nAge > 16 yrs (no age limit if same as HSC donor).\nNo HLA matching required.\nFulfills generally accepted criteria for allogeneic HSC donation.\nInformed consent given by donor or his/her guardian if of minor age.\n\nExclusion Criteria:\n\nPatient exclusion criteria\n\nHIV positive.\nActive uncontrolled infection at time of scheduled MSC infusion.\nRelapsing or progressing malignancy.\n\nMSC donor exclusion criteria\n\nHIV positive\nKnown allergy to Lidocaine\nIf donor other than HSC donor : any risk factor for transmissible infectious diseases."
      ],
      "EnrollmentCount": [
            "100"
      ],
      "EnrollmentType": [
            "Anticipated"
      ],
      "EventGroupDeathsNumAffected": [],
      "EventGroupDeathsNumAtRisk": [],
      "EventGroupDescription": [],
      "EventGroupId": [],
      "EventGroupOtherNumAffected": [],
      "EventGroupOtherNumAtRisk": [],
      "EventGroupSeriousNumAffected": [],
      "EventGroupSeriousNumAtRisk": [],
      "EventGroupTitle": [],
      "EventsDescription": [],
      "EventsFrequencyThreshold": [],
      "EventsTimeFrame": [],
      "ExpAccTypeIndividual": [],
      "ExpAccTypeIntermediate": [],
      "ExpAccTypeTreatment": [],
      "ExpandedAccessNCTId": [],
      "ExpandedAccessStatusForNCTId": [],
      "FDAAA801Violation": [],
      "FlowAchievementComment": [],
      "FlowAchievementGroupId": [],
      "FlowAchievementNumSubjects": [],
      "FlowAchievementNumUnits": [],
      "FlowDropWithdrawComment": [],
      "FlowDropWithdrawType": [],
      "FlowGroupDescription": [],
      "FlowGroupId": [],
      "FlowGroupTitle": [],
      "FlowMilestoneComment": [],
      "FlowMilestoneType": [],
      "FlowPeriodTitle": [],
      "FlowPreAssignmentDetails": [],
      "FlowReasonComment": [],
      "FlowReasonGroupId": [],
      "FlowReasonNumSubjects": [],
      "FlowReasonNumUnits": [],
      "FlowRecruitmentDetails": [],
      "FlowTypeUnitsAnalyzed": [],
      "Gender": [
            "All"
      ],
      "GenderBased": [],
      "GenderDescription": [],
      "HasExpandedAccess": [
            "No"
      ],
      "HealthyVolunteers": [
            "Accepts Healthy Volunteers"
      ],
      "IPDSharing": [],
      "IPDSharingAccessCriteria": [],
      "IPDSharingDescription": [],
      "IPDSharingInfoType": [],
      "IPDSharingTimeFrame": [],
      "IPDSharingURL": [],
      "InterventionAncestorId": [],
      "InterventionAncestorTerm": [],
      "InterventionArmGroupLabel": [
            "1",
            "2",
            "3"
      ],
      "InterventionBrowseBranchAbbrev": [],
      "InterventionBrowseBranchName": [],
      "InterventionBrowseLeafAsFound": [],
      "InterventionBrowseLeafId": [],
      "InterventionBrowseLeafName": [],
      "InterventionBrowseLeafRelevance": [],
      "InterventionDescription": [
            "Mesenchymal Stem Cell infusion"
      ],
      "InterventionMeshId": [],
      "InterventionMeshTerm": [],
      "InterventionName": [
            "Mesenchymal stem cells"
      ],
      "InterventionOtherName": [],
      "InterventionType": [
            "Biological"
      ],
      "IsFDARegulatedDevice": [],
      "IsFDARegulatedDrug": [],
      "IsPPSD": [],
      "IsUSExport": [],
      "IsUnapprovedDevice": [],
      "Keyword": [
            "Mesenchymal stem cells",
            "Graft-versus-host disease",
            "Poor graft function",
            "Chimerism",
            "Hematopoietic cell transplantation recipients",
            "Low donor T-cell chimerism"
      ],
      "LargeDocDate": [],
      "LargeDocFilename": [],
      "LargeDocHasICF": [],
      "LargeDocHasProtocol": [],
      "LargeDocHasSAP": [],
      "LargeDocLabel": [],
      "LargeDocTypeAbbrev": [],
      "LargeDocUploadDate": [],
      "LastKnownStatus": [],
      "LastUpdatePostDate": [
            "September 21, 2022"
      ],
      "LastUpdatePostDateType": [
            "Actual"
      ],
      "LastUpdateSubmitDate": [
            "September 19, 2022"
      ],
      "LeadSponsorClass": [
            "OTHER"
      ],
      "LeadSponsorName": [
            "University of Liege"
      ],
      "LimitationsAndCaveatsDescription": [],
      "LocationCity": [
            "Edeghem",
            "Brussels",
            "Brussels",
            "Brussels",
            "Leuven",
            "Gent",
            "Haine St Paul",
            "Yvoir",
            "Brugge",
            "Antwerpen",
            "Liege",
            "Maastricht"
      ],
      "LocationContactEMail": [
            "zwi.berneman@uza.be",
            "alice.ferster@huderf.be",
            "Rik.Schots@uzbrussel.be",
            "Augustin.Ferrant@uclouvain.be",
            "johan.maertens@uz.kuleuven.ac.be",
            "koen.theunissen@uz.kuleuven.ac.be",
            "Lucien.Noens@Ugent.be",
            "nicole.straetmans@scarlet.be",
            "chantal.doyen@sang.ucl.ac.be",
            "dominik.selleslag@azbrugge.be",
            "pierre.zachee@zna.be",
            "yves.beguin@chu.ulg.ac.be",
            "F.Baron@ulg.ac.be",
            "h.schouten@intmed.unimaas.nl"
      ],
      "LocationContactName": [
            "Zwi Berneman, MD, PhD",
            "Zwi Berneman, MD, PhD",
            "Alice Ferster, MD",
            "Alice Ferster, MD",
            "Rik Schots, MD, PhD",
            "Rick Schots, MD, PhD",
            "Augustin Ferrant, MD, PhD",
            "Augustin Ferrant, MD, PhD",
            "Johan Maertens, MD",
            "Koen Theunissen, MD",
            "Johan Maertens, MD",
            "Koen Theunissen, MD",
            "Lucien Noens, MD, PhD",
            "Lucien Noens, MD, PhD",
            "Nicole Straetmans, MD",
            "Nicole Straetmans, MD",
            "Chantal Doyen, MD",
            "Chantal Doyen, MD",
            "Domonik Selleslag, MD",
            "Dominik Selleslag, MD",
            "Pierre Zach\u00e9e, MD, PhD",
            "Pierre Zach\u00e9e, MD, PhD",
            "Yves Beguin, MD/PhD",
            "Frederic Baron, MD/PhD",
            "Yves Beguin, MD, PhD",
            "Frederic Baron, MD, PhD",
            "Chantal Lechanteur, PhD",
            "Etienne Baudoux, MD",
            "Evelyne Willems, MD",
            "Pascale Fr\u00e8re, MD, PhD",
            "Bernard De Prijck, MD",
            "Harry Schouten, MD",
            "Harry Schouten, MD"
      ],
      "LocationContactPhone": [
            "32(03)8213250",
            "32(02)4773283",
            "32 (02) 4763105",
            "32 (02) 7641880",
            "32- 16 33 22 11",
            "32- 16 33 22 11",
            "32(09) 332 21 31",
            "32(064) 235071",
            "32(081)423831",
            "32 (050) 453060",
            "32(03)2177111",
            "32-4-366 72 01",
            "32-4-366 72 01",
            "+31-43-3876543"
      ],
      "LocationContactPhoneExt": [],
      "LocationContactRole": [
            "Contact",
            "Principal Investigator",
            "Contact",
            "Principal Investigator",
            "Contact",
            "Principal Investigator",
            "Contact",
            "Principal Investigator",
            "Contact",
            "Contact",
            "Principal Investigator",
            "Principal Investigator",
            "Contact",
            "Principal Investigator",
            "Contact",
            "Principal Investigator",
            "Contact",
            "Principal Investigator",
            "Contact",
            "Principal Investigator",
            "Contact",
            "Principal Investigator",
            "Contact",
            "Contact",
            "Principal Investigator",
            "Principal Investigator",
            "Principal Investigator",
            "Sub-Investigator",
            "Sub-Investigator",
            "Sub-Investigator",
            "Sub-Investigator",
            "Contact",
            "Principal Investigator"
      ],
      "LocationCountry": [
            "Belgium",
            "Belgium",
            "Belgium",
            "Belgium",
            "Belgium",
            "Belgium",
            "Belgium",
            "Belgium",
            "Belgium",
            "Belgium",
            "Belgium",
            "Netherlands"
      ],
      "LocationFacility": [
            "UZA",
            "H\u00f4pital des enfants Reine Fabiola",
            "AZ VUB Jette",
            "Cliniques universitaires Saint-Luc- Universit\u00e9 Catholique de Louvain",
            "AZ Gasthuisberg Leuven",
            "UZ Gent",
            "H\u00f4pital de Jolimont",
            "Cliniques Universitaires Mont-Godinne",
            "AZ St Jan",
            "H\u00f4pital Stuyvenberg",
            "CHU Sart Tilman",
            "University Hospital Maastricht"
      ],
      "LocationState": [
            "Antwerpen",
            "Brabant",
            "Brabant",
            "Brabant",
            "Flamish Brabant",
            "Flanders Ost",
            "Hainaut",
            "Namur",
            "West Flanders",
            "Limburg"
      ],
      "LocationStatus": [
            "Recruiting",
            "Recruiting",
            "Recruiting",
            "Recruiting",
            "Recruiting",
            "Recruiting",
            "Recruiting",
            "Recruiting",
            "Recruiting",
            "Recruiting",
            "Recruiting",
            "Not yet recruiting"
      ],
      "LocationZip": [
            "2650",
            "1020",
            "1090",
            "1200",
            "3000",
            "9000",
            "7100",
            "5530",
            "8000",
            "2060",
            "4000",
            "6200"
      ],
      "MaximumAge": [],
      "MinimumAge": [],
      "NCTIdAlias": [],
      "OfficialTitle": [
            "Infusion of Mesenchymal Stem Cells as Treatment for Steroid-Resistant Grade II to IV Acute GVHD or Poor Graft Function: a Multicenter Phase II Study"
      ],
      "OrgClass": [
            "OTHER"
      ],
      "OrgFullName": [
            "University of Liege"
      ],
      "OrgStudyId": [
            "TJB0703P1"
      ],
      "OrgStudyIdDomain": [],
      "OrgStudyIdLink": [],
      "OrgStudyIdType": [],
      "OtherEventAssessmentType": [],
      "OtherEventNotes": [],
      "OtherEventOrganSystem": [],
      "OtherEventSourceVocabulary": [],
      "OtherEventStatsGroupId": [],
      "OtherEventStatsNumAffected": [],
      "OtherEventStatsNumAtRisk": [],
      "OtherEventStatsNumEvents": [],
      "OtherEventTerm": [],
      "OtherOutcomeDescription": [],
      "OtherOutcomeMeasure": [],
      "OtherOutcomeTimeFrame": [],
      "OutcomeAnalysisCILowerLimit": [],
      "OutcomeAnalysisCILowerLimitComment": [],
      "OutcomeAnalysisCINumSides": [],
      "OutcomeAnalysisCIPctValue": [],
      "OutcomeAnalysisCIUpperLimit": [],
      "OutcomeAnalysisCIUpperLimitComment": [],
      "OutcomeAnalysisDispersionType": [],
      "OutcomeAnalysisDispersionValue": [],
      "OutcomeAnalysisEstimateComment": [],
      "OutcomeAnalysisGroupDescription": [],
      "OutcomeAnalysisGroupId": [],
      "OutcomeAnalysisNonInferiorityComment": [],
      "OutcomeAnalysisNonInferiorityType": [],
      "OutcomeAnalysisOtherAnalysisDescription": [],
      "OutcomeAnalysisPValue": [],
      "OutcomeAnalysisPValueComment": [],
      "OutcomeAnalysisParamType": [],
      "OutcomeAnalysisParamValue": [],
      "OutcomeAnalysisStatisticalComment": [],
      "OutcomeAnalysisStatisticalMethod": [],
      "OutcomeAnalysisTestedNonInferiority": [],
      "OutcomeCategoryTitle": [],
      "OutcomeClassDenomCountGroupId": [],
      "OutcomeClassDenomCountValue": [],
      "OutcomeClassDenomUnits": [],
      "OutcomeClassTitle": [],
      "OutcomeDenomCountGroupId": [],
      "OutcomeDenomCountValue": [],
      "OutcomeDenomUnits": [],
      "OutcomeGroupDescription": [],
      "OutcomeGroupId": [],
      "OutcomeGroupTitle": [],
      "OutcomeMeasureAnticipatedPostingDate": [],
      "OutcomeMeasureCalculatePct": [],
      "OutcomeMeasureDenomUnitsSelected": [],
      "OutcomeMeasureDescription": [],
      "OutcomeMeasureDispersionType": [],
      "OutcomeMeasureParamType": [],
      "OutcomeMeasurePopulationDescription": [],
      "OutcomeMeasureReportingStatus": [],
      "OutcomeMeasureTimeFrame": [],
      "OutcomeMeasureTitle": [],
      "OutcomeMeasureType": [],
      "OutcomeMeasureTypeUnitsAnalyzed": [],
      "OutcomeMeasureUnitOfMeasure": [],
      "OutcomeMeasurementComment": [],
      "OutcomeMeasurementGroupId": [],
      "OutcomeMeasurementLowerLimit": [],
      "OutcomeMeasurementSpread": [],
      "OutcomeMeasurementUpperLimit": [],
      "OutcomeMeasurementValue": [],
      "OverallOfficialAffiliation": [
            "CHU-ULg",
            "CHU-ULg",
            "KU Leuven",
            "Maastricht University Medical Center",
            "Stuyvenberg Hospital Antwerpen",
            "UZA Antwerpen",
            "UZ-Gent",
            "AZ VUB Jette",
            "AZ St. Jan Bugge",
            "UCL St. Luc Brussels",
            "Cliniques Universitaires Mont-Godinne at Yvoir",
            "H\u00f4pital de Jolimont at Haine-St-Paul",
            "H\u00f4pital des enfants Reine Fabiola at Brussels"
      ],
      "OverallOfficialName": [
            "Yves Beguin, MD, PhD",
            "Fr\u00e9d\u00e9ric Baron, MD, PhD",
            "Johan Maertens, MD",
            "Harry Schouten, MD",
            "Pierre Zach\u00e9e, MD",
            "Zwi Berneman, MD",
            "Lucien Noens, MD, PhD",
            "Rick Schots, MD, PhD",
            "Dominik Selleslag, MD",
            "Augustin Ferrant, MD, PhD",
            "Chantal Doyen, MD",
            "Nicole Straetmans, MD",
            "Nicole Ferster, MD"
      ],
      "OverallOfficialRole": [
            "Study Chair",
            "Study Chair",
            "Principal Investigator",
            "Principal Investigator",
            "Principal Investigator",
            "Principal Investigator",
            "Principal Investigator",
            "Principal Investigator",
            "Principal Investigator",
            "Principal Investigator",
            "Principal Investigator",
            "Principal Investigator",
            "Principal Investigator"
      ],
      "OverallStatus": [
            "Recruiting"
      ],
      "OversightHasDMC": [
            "No"
      ],
      "PatientRegistry": [],
      "Phase": [
            "Phase 2"
      ],
      "PointOfContactEMail": [],
      "PointOfContactOrganization": [],
      "PointOfContactPhone": [],
      "PointOfContactPhoneExt": [],
      "PointOfContactTitle": [],
      "PrimaryCompletionDate": [
            "August 2024"
      ],
      "PrimaryCompletionDateType": [
            "Anticipated"
      ],
      "PrimaryOutcomeDescription": [],
      "PrimaryOutcomeMeasure": [
            "Arm 1. Efficacy of MSC infusion as treatment for steroid-resistant grade II - IV acute GVHD.",
            "Arm 2. Efficacy of MSC infusion as treatment for poor graft function",
            "Arm 3. Efficacy of MSC infusion followed by donor lymphocyte infusion for preventing graft rejection in patients with low or failing donor T-cell chimerism after allogeneic HCT"
      ],
      "PrimaryOutcomeTimeFrame": [
            "30 days",
            "180 days",
            "180 days"
      ],
      "ReferenceCitation": [],
      "ReferencePMID": [],
      "ReferenceType": [],
      "RemovedCountry": [],
      "ResponsiblePartyInvestigatorAffiliation": [
            "University of Liege"
      ],
      "ResponsiblePartyInvestigatorFullName": [
            "Yves Beguin"
      ],
      "ResponsiblePartyInvestigatorTitle": [
            "Prof"
      ],
      "ResponsiblePartyOldNameTitle": [],
      "ResponsiblePartyOldOrganization": [],
      "ResponsiblePartyType": [
            "Principal Investigator"
      ],
      "ResultsFirstPostDate": [],
      "ResultsFirstPostDateType": [],
      "ResultsFirstPostedQCCommentsDate": [],
      "ResultsFirstPostedQCCommentsDateType": [],
      "ResultsFirstSubmitDate": [],
      "ResultsFirstSubmitQCDate": [],
      "RetractionPMID": [],
      "RetractionSource": [],
      "SamplingMethod": [],
      "SecondaryId": [],
      "SecondaryIdDomain": [],
      "SecondaryIdLink": [],
      "SecondaryIdType": [],
      "SecondaryOutcomeDescription": [],
      "SecondaryOutcomeMeasure": [
            "Toxicity of MSC infusion"
      ],
      "SecondaryOutcomeTimeFrame": [
            "180 days"
      ],
      "SeeAlsoLinkLabel": [],
      "SeeAlsoLinkURL": [],
      "SeriousEventAssessmentType": [],
      "SeriousEventNotes": [],
      "SeriousEventOrganSystem": [],
      "SeriousEventSourceVocabulary": [],
      "SeriousEventStatsGroupId": [],
      "SeriousEventStatsNumAffected": [],
      "SeriousEventStatsNumAtRisk": [],
      "SeriousEventStatsNumEvents": [],
      "SeriousEventTerm": [],
      "StartDate": [
            "January 2008"
      ],
      "StartDateType": [
            "Actual"
      ],
      "StatusVerifiedDate": [
            "September 2022"
      ],
      "StdAge": [
            "Child",
            "Adult",
            "Older Adult"
      ],
      "StudyFirstPostDate": [
            "January 29, 2008"
      ],
      "StudyFirstPostDateType": [
            "Estimate"
      ],
      "StudyFirstSubmitDate": [
            "January 16, 2008"
      ],
      "StudyFirstSubmitQCDate": [
            "January 28, 2008"
      ],
      "StudyPopulation": [],
      "StudyType": [
            "Interventional"
      ],
      "SubmissionMCPReleaseN": [],
      "SubmissionReleaseDate": [],
      "SubmissionResetDate": [],
      "SubmissionUnreleaseDate": [],
      "TargetDuration": [],
      "UnpostedEventDate": [],
      "UnpostedEventType": [],
      "UnpostedResponsibleParty": [],
      "VersionHolder": [
            "October 07, 2022"
      ],
      "WhyStopped": []
}